212 related articles for article (PubMed ID: 14561696)
1. What brings pericytes to tumor vessels?
Jain RK; Booth MF
J Clin Invest; 2003 Oct; 112(8):1134-6. PubMed ID: 14561696
[TBL] [Abstract][Full Text] [Related]
2. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.
Abramsson A; Lindblom P; Betsholtz C
J Clin Invest; 2003 Oct; 112(8):1142-51. PubMed ID: 14561699
[TBL] [Abstract][Full Text] [Related]
3. The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade.
Nisancioglu MH; Betsholtz C; Genové G
Cancer Res; 2010 Jun; 70(12):5109-15. PubMed ID: 20501841
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.
Chantrain CF; Henriet P; Jodele S; Emonard H; Feron O; Courtoy PJ; DeClerck YA; Marbaix E
Eur J Cancer; 2006 Feb; 42(3):310-8. PubMed ID: 16406506
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulphate requirement in platelet-derived growth factor B-mediated pericyte recruitment.
Kurup S; Abramsson A; Li JP; Lindahl U; Kjellen L; Betsholtz C; Gerhardt H; Spillmann D
Biochem Soc Trans; 2006 Jun; 34(Pt 3):454-5. PubMed ID: 16709185
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
Lee A; Frischer J; Serur A; Huang J; Bae JO; Kornfield ZN; Eljuga L; Shawber CJ; Feirt N; Mansukhani M; Stempak D; Baruchel S; Glade Bender J; Kandel JJ; Yamashiro DJ
Cancer Res; 2006 Apr; 66(8):4378-84. PubMed ID: 16618763
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factors in the developing avian heart and maturating coronary vasculature.
Van Den Akker NM; Lie-Venema H; Maas S; Eralp I; DeRuiter MC; Poelmann RE; Gittenberger-De Groot AC
Dev Dyn; 2005 Aug; 233(4):1579-88. PubMed ID: 15973731
[TBL] [Abstract][Full Text] [Related]
8. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities.
Bjarnegård M; Enge M; Norlin J; Gustafsdottir S; Fredriksson S; Abramsson A; Takemoto M; Gustafsson E; Fässler R; Betsholtz C
Development; 2004 Apr; 131(8):1847-57. PubMed ID: 15084468
[TBL] [Abstract][Full Text] [Related]
10. Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis.
Zhang Y; Cedervall J; Hamidi A; Herre M; Viitaniemi K; D'Amico G; Miao Z; Unnithan RVM; Vaccaro A; van Hooren L; Georganaki M; Thulin Å; Qiao Q; Andrae J; Siegbahn A; Heldin CH; Alitalo K; Betsholtz C; Dimberg A; Olsson AK
Cancer Res; 2020 Aug; 80(16):3345-3358. PubMed ID: 32586981
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.
Shih AH; Dai C; Hu X; Rosenblum MK; Koutcher JA; Holland EC
Cancer Res; 2004 Jul; 64(14):4783-9. PubMed ID: 15256447
[TBL] [Abstract][Full Text] [Related]
13. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.
Ejaz S; Chekarova I; Ejaz A; Sohail A; Lim CW
Diabetes Obes Metab; 2008 Jan; 10(1):53-63. PubMed ID: 17941874
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances in pericytes angiogenic signaling pathways].
Lu WB; Shi XR; Xiu RJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):423-6. PubMed ID: 21914358
[No Abstract] [Full Text] [Related]
15. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
16. New insights to vascular smooth muscle cell and pericyte differentiation of mouse embryonic stem cells in vitro.
Lindskog H; Athley E; Larsson E; Lundin S; Hellström M; Lindahl P
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1457-64. PubMed ID: 16627807
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.
Jo N; Mailhos C; Ju M; Cheung E; Bradley J; Nishijima K; Robinson GS; Adamis AP; Shima DT
Am J Pathol; 2006 Jun; 168(6):2036-53. PubMed ID: 16723717
[TBL] [Abstract][Full Text] [Related]
18. Pericytes and vascular stability.
von Tell D; Armulik A; Betsholtz C
Exp Cell Res; 2006 Mar; 312(5):623-9. PubMed ID: 16303125
[TBL] [Abstract][Full Text] [Related]
19. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
[TBL] [Abstract][Full Text] [Related]
20. Early contribution of pericytes to angiogenic sprouting and tube formation.
Ozerdem U; Stallcup WB
Angiogenesis; 2003; 6(3):241-9. PubMed ID: 15041800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
